Adipokines, Inflammation, and Metabolic Diseases
Adipokines, Inflammation, and Metabolic Diseases is a research topic within Epidemiology. Science Explorer counts 48k research works in it since 1950. 24.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the intricate relationship between inflammation and obesity, focusing on the impact of chronic inflammation in adipose tissue on the development of obesity-related metabolic disorders such as insulin resistance, cardiovascular disease, and type 2 diabetes. The role of adipokines, macrophage accumulation, and C-reactive protein in linking inflammation to metabolic syndrome is also extensively studied.
- Inflammation
- Obesity
- Adipose Tissue
- Insulin Resistance
- Cardiovascular Disease
- Adipokines
- Macrophages
- C-Reactive Protein
- Metabolic Syndrome
- Type 2 Diabetes
- Research works
- 48k fractional, since 1950
- In the world top 10%
- 12k per year above
- Top-10% rate
- 24.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +7% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Adipokines, Inflammation, and Metabolic Diseases research?
By volume, China and the United States publish the most (2.2k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.2k works
- 2 United States 1.2k works
- 3 India 432 works
- 4 Iran 300 works
- 5 South Korea 262 works
- 6 Türkiye 259 works
- 7 Japan 250 works
- 8 Germany 217 works
- 9 Italy 207 works
- 10 Spain 200 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Adipokines, Inflammation, and Metabolic Diseases research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Adipokines, Inflammation, and Metabolic Diseases research, followed by Capital Medical University and Nanjing Medical University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 44 works
- 2 Capital Medical UniversityChina 27 works
- 3 Nanjing Medical UniversityChina 27 works
- 4 Shanghai Jiao Tong UniversityChina 24 works
- 5 Central South UniversityChina 24 works
- 6 Tehran University of Medical SciencesIran 23 works
- 7 Sichuan UniversityChina 22 works
- 8 Harvard UniversityUnited States 22 works
- 9 Sun Yat-sen UniversityChina 21 works
- 10 University of BaghdadIraq 20 works
Who are the leading researchers in Adipokines, Inflammation, and Metabolic Diseases?
The most-cited researchers publishing on Adipokines, Inflammation, and Metabolic Diseases include Mika Kivimäki, Alireza Esteghamati and Emelia J. Benjamin.
- 1 Mika Kivimäki United Kingdom 6.7k citations
- 2 Alireza Esteghamati Iran 6.1k citations
- 3 Emelia J. Benjamin United States 6k citations
- 4 Hermann Brenner Germany 5.8k citations
- 5 Amirhossein Sahebkar Iran 5.6k citations
- 6 Valentı́n Fuster United States 5.4k citations
- 7 Winfried März Germany 5.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Adipokines, Inflammation, and Metabolic Diseases research done?
The largest centres of Adipokines, Inflammation, and Metabolic Diseases research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Seoul (South Korea).
Where is the best place to study Adipokines, Inflammation, and Metabolic Diseases?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu University of Traditional Chinese Medicine and Southern Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 61.1 | 35.7% | 5.7× | 44 | +26.8% |
| 2 | Chengdu University of Traditional Chinese MedicineChina | 55.4 | 51.4% | 6.2× | 11 | — |
| 3 | Southern Medical UniversityChina | 55.1 | 39.2% | 6.4× | 19 | +30.1% |
| 4 | Nanjing University of Chinese MedicineChina | 53.8 | 40.1% | 6.5× | 13 | +82.7% |
| 5 | Capital Medical UniversityChina | 51.5 | 32.4% | 5.8× | 27 | -4.0% |
| 6 | Jilin UniversityChina | 51.2 | 46.7% | 1.6× | 13 | +188.8% |
| 7 | Guangzhou Medical UniversityChina | 50.7 | 45.1% | 4.8× | 10 | +80.4% |
| 8 | Nanjing Medical UniversityChina | 50.2 | 28.9% | 6.5× | 27 | -15.5% |
| 9 | Karolinska InstitutetSweden | 50.0 | 32.3% | 4.6× | 16 | -6.7% |
| 10 | Mashhad University of Medical SciencesIran | 49.9 | 25.4% | 6.0× | 12 | +180.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Adipokines, Inflammation, and Metabolic Diseases research growing?
Output in 2018–2022 was 7% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Adipokines, Inflammation, and Metabolic Diseases.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.